Bengaluru-based STEERLife, a pioneer in pharmaceutical development technologies, and Pune-based startup Callidus Research Laboratories, a formulation development services company with a wealth of experience in comprehensive pharmaceutical drug development, have forged a strategic partnership to accelerate drug development for global markets. STEERLife is a division of STEER World.

The collaboration combines STEERLife's advanced Hot Melt Extrusion (HME) and Continuous Processing Technologies with Callidus' Pharmaceutical Drug Development Expertise, addressing the global demand for innovative drug formulations and development.

By leveraging their combined strengths, STEERLife and Callidus will provide worldwide clients with advanced drug development services utilising Hot Melt Extrusion (HME) technology. This partnership enables both organisations to integrate their specialised knowledge and skills, yielding innovative solutions and enhanced product offerings. Additionally, the collaboration facilitates network, contact, and market reach sharing, allowing both companies to enter new regions and customer segments. Together, they will meet the global demand for next-generation pharmaceutical formulations, serving generic and brand companies.

This partnership also enables end-to-end drug development for highly potent APIs. Beyond their complementary capabilities, the organisations’ collaboration is fuelled by their shared commitment to pushing the boundaries of innovation to further futuristic product development for global markets.